Reproduction after breast cancer
| dc.contributor.author | Zervoudis, S. | en |
| dc.contributor.author | Iatrakis, G. | en |
| dc.contributor.author | Navrozoglou, I. | en |
| dc.date.accessioned | 2015-11-24T18:54:02Z | |
| dc.date.available | 2015-11-24T18:54:02Z | |
| dc.identifier.issn | 1532-1932 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18642 | |
| dc.rights | Default Licence | - |
| dc.subject | Antineoplastic Combined Chemotherapy Protocols/adverse effects | en |
| dc.subject | Breast Neoplasms/complications/diagnosis/epidemiology/*therapy | en |
| dc.subject | *Cryopreservation/methods | en |
| dc.subject | Drug Therapy, Combination | en |
| dc.subject | *Embryo Transfer | en |
| dc.subject | Female | en |
| dc.subject | Fertility Agents, Female/therapeutic use | en |
| dc.subject | *Fertilization in Vitro | en |
| dc.subject | Gonadotropin-Releasing Hormone/agonists | en |
| dc.subject | Humans | en |
| dc.subject | Incidence | en |
| dc.subject | Infertility, Female/chemically induced/drug therapy | en |
| dc.subject | Ovary/transplantation | en |
| dc.subject | Ovulation Induction | en |
| dc.subject | Pregnancy | en |
| dc.subject | Primary Ovarian Insufficiency/chemically induced/complications/*drug therapy | en |
| dc.subject | Reproduction/*drug effects | en |
| dc.subject | Romania/epidemiology | en |
| dc.subject | Selective Estrogen Receptor Modulators/therapeutic use | en |
| dc.subject | Tamoxifen/therapeutic use | en |
| dc.subject | World Health | en |
| dc.title | Reproduction after breast cancer | en |
| heal.abstract | Breast cancer is the most frequently occurring cancer in women of developed countries, and as a result of new developments in breast cancer treatment, more women are cured after being diagnosed with this disease. It is important that fertility preservation strategies are addressed before chemotherapy, because chemotherapy may induce premature ovarian failure (depending on the woman's age, the drugs used, the dosage and duration of treatment). Among possible solutions are embryos or oocytes cryopreservation, ovarian tissue cryopreservation-freezing with a subsequent orthotopic and heterotopic autotransplantation, whole ovary cryopreservation, ovarian suppression with gonadotropin-releasing hormone (GnRH) analogues, which inhibit ovarian follicular depletion induced by chemotherapeutic agents and in vitro fertilisation (IVF) after ovulation induction with aromatase inhibitors or tamoxifen. | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.primary | 10.1016/j.bpobgyn.2009.08.008 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/20170848 | - |
| heal.identifier.secondary | http://ac.els-cdn.com/S1521693409001114/1-s2.0-S1521693409001114-main.pdf?_tid=81a029213e72567f24a878769b1e7e02&acdnat=1333638787_63e9e37e58c1641a609eef936775067e | - |
| heal.journalName | Best Pract Res Clin Obstet Gynaecol | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2010 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: